Department of Medicine

June 8, 2017

Pal to lead VICC Cancer Health Disparities program

Clinical geneticist Tuya Pal, M.D., has joined Vanderbilt-Ingram Cancer Center (VICC) as associate director of Cancer Health Disparities. Pal also has been named an associate professor of Medicine and Ingram Associate Professor of Cancer Research.

By VUMC News and Communications
June 8, 2017

VUMC lands renewal of Clinical and Translational Science Award

Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).

By Bill Snyder
June 8, 2017

Coffey lands major NCI award to support colorectal cancer research

Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer.

By Bill Snyder
June 8, 2017

NIDDK renews Vanderbilt’s diabetes research grant

The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).

By Jill Clendening
June 8, 2017

Project reveals importance of cancer gene mutation testing

An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.

By VUMC News and Communications
May 18, 2017

Glowing receptors help find and track cancerous growth

Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth.

By Bill Snyder
May 15, 2017

RSV-HRV viral interference

RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.
By Leigh MacMillan
May 11, 2017

EETs contribute to insulin sensitivity

Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.
By Leigh MacMillan
May 4, 2017

Lovly elected to American Society for Clinical Investigation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt, has been elected to The American Society for Clinical Investigation (ASCI).
By VUMC News and Communications
May 4, 2017

Three faculty members elected to Association of American Physicians

The Association of American Physicians (AAP) is an honorary medical society founded in 1885 by Sir William Osler and six other physicians for “the advancement of scientific and practical medicine.” This year, 60 additional physician scientists were elected to the association, including three Vanderbilt faculty members.
By Paul Govern
May 3, 2017

Therapeutic targets for diabetes

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.
By Leigh MacMillan
April 27, 2017

Aronoff elected to microbiology academy

Infectious diseases specialist David Aronoff, M.D., recently became one of 73 new fellows of the American Academy of Microbiology, an honorific leadership group within the American Society of Microbiology.
By Paul Govern
April 27, 2017

HIV-infected people have higher risk of heart failure

The first large study to report that HIV-infected people have a significantly higher risk of heart failure in the antiretroviral therapy era has been published in JAMA Cardiology.
By Jessica Pasley
1 … 80 81 82 83 84 … 116